l -Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Objective The authors conducted two multicenter sequential parallel comparison design trials to investigate the effect of L-methylfolate augmentation in the treatment of major depressive disorder in patients who had a partial response or no response to selective serotonin reuptake inhibitors (SSRIs). Method In the first trial, 148 outpatients with SSRI-resistant major depressive disorder were enrolled in a 60-day study divided into two 30-day periods. Patients were randomly assigned, in a 2:3:3 ratio, to receive L-methylfolate for 60 days (7.5 mg/day for 30 days followed by 15 mg/day for 30 days), placebo for 30 days followed by L-methylfolate (7.5 mg/day) for 30 days, or placebo for 60 days. SSRI dosages were kept constant throughout the study. In the second trial, with 75 patients, the design was identical to the first, except that the l-methylfolate dosage was 15 mg/day during both 30-day periods. Results In the first trial, no significant difference was observed in outcomes between the treatment groups. In the second trial, adjunctive L-methylfolate at 15 mg/day showed significantly greater efficacy compared with continued SSRI therapy plus placebo on both primary outcome measures (response rate and degree of change in depression symptom score) and two secondary outcome measures of symptom severity. The number needed to treat for response was approximately six in favor of adjunctive L-methylfolate at 15 mg/day. L-Methylfolate was well tolerated, with rates of adverse even…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Folate has been studied in a placebo-controlled trial an adjunctive treatment to fluoxetine, with significantly greater improvement in the folate group, a difference most pronounced in women [43].”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [43]
In the citing paper
“94% of women who received fluoxetine with the addition of folate 500 mcg per day were treatment responders, compared to 61% of those who received fluoxetine and placebo.”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [43]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968
Nelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552
Self-citationFava, M., Evins, A. E., Dorer, D. J., & Schoenfeld, D. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000069738 · Cited by 452
Self-citationEnhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Coppen, A., & Bailey, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00153-1 · Cited by 337
Lithium Augmentation in Treatment-Resistant Depression: Meta-Analysis of Placebo-Controlled Studies
Bauer, M., & Döpfmer, S. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00006 · Cited by 304
Research works printed but not linked: 3
- 10.3109/10401230209147396 · doi:10.3109/10401230209147396 · Paper page
- Passeri M, 1993, Aging (Milano), 5, 63
- First MB, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders With Psychotic Screen (SCID-I/P w/ Psychotic Screen) Version 2.0
Cited by
Items 201–285 of 285
Treatments for Comorbid Anxiety and Mood Disorders
Sarris, J. J., & Mischoulon, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-42307-4_6 · Cited by 2
Self-citationAntidepressant Trials: Are the Diminishing Effect Sizes of Efficacy Trials Avoidable?
Rickels, K., & Robinson, D. S. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000796 · Cited by 2
“And indeed, Fava’s group recently reported results of a positive AD augmentation trial with methylfolate in treatment-resistant depressed patients.(15) Using a placebo-controlled, nonparallel group study design with only 75 patients and 6 sites, these investigators detected significant augmentation of AD treatment wit…”
ResultSelf-citationDepression and pharmacogenetics: A psychiatric pharmacist's perspective
McGrane, I. R., & Mertens, S. (2018) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2018.02.003 · Cited by 2
Pahlajani, S. S., & Najjar, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00004-0 · Cited by 2
Sequential parallel comparison design with two coprimary endpoints
Homma, G., & Daimon, T. (2019) · Pharmaceutical Statistics · doi:10.1002/pst.1987 · Cited by 2
Distribution of Pharmacogene Allele and Phenotype Frequencies in Brazilian Psychiatric Patients
May, G., de Souza, B. R., Gueuvoghlanian‐Silva, B. Y., Camilo, E., Mostardeiro, S. R., May, P. P. B., Mateo, E. C. C., Vietta, G. G., & Hoss, G. R. W. (2023) · Pharmacogenomics · doi:10.2217/pgs-2023-0075 · Cited by 2
Diet and depression : an epidemiological study
Ruusunen, A. A. (2013) · UEF eRepo (University of Eastern Finland) · Cited by 41
Effect of folic acid supplementation on mental health in the antenatal and postnatal period
Zeynep, B. A. L., KARSLIOĞLU, G., & Uçar, T. (2022) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1167060 · Cited by 1
Trkulja, V., & Barić, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_6 · Cited by 1
Weber, N., Striegel, L., Methner, Y., Brandl, B., Groehn, V., Knapp, J.-P., Skurk, T., & Rychlik, M. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70453 · Cited by 1
Fornaro, M., Lorenzo, C. D., Núñez, N. A., Miola, A., Calati, R., Carvalho, A. F., Steardo, L., Stubbs, B., Mischoulon, D., Correll, C. U., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03759-1 · Cited by 1
Self-citationCEQUEL the sequel: bipolar disorder combination therapy
Malhi, G. S. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00520-9 · Cited by 1
Novel and Investigational Drugs in Depression
Shapiro, D. N., & Stahl, S. M. (2014) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2014/11590 · Cited by 1
Nutritional Effects on Epigenetics in Psychiatry
Peedicayil, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00027-9 · Cited by 1
Theory Into Practice—Addressing the Homocysteine Basis of Depression
Farah, A. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150901-07 · Cited by 1
Pathogenetic effects of folate-containing combined oral contraceptive in patients with PCOS
Andreeva, E. N., & Absatarova, Y. S. (2018) · Russian Journal of Human Reproduction · doi:10.17116/repro201824321 · Cited by 2
Augmentation Strategies for Treatment-Resistant Disorders
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372300.as09 · Cited by 1
Sousa, L. J. D. R., de Paula, C. A., & de Almeida, M. E. F. (2022) · Research Society and Development · doi:10.33448/rsd-v11i7.29445 · Cited by 8
Pharmacotherapy in Prader-Willi Syndrome
Forster, J. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-98171-6_22 · Cited by 3
Nutritional effects on epigenetics in psychiatry
Peedicayil, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823577-5.00028-3 · Cited by 2
Chapter 9. Augmentation Strategies for Treatment-Resistant Disorders
(2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551289.cd09 · Cited by 1
Chapter 13. Diet and Nutrition in the Prevention and Adjuvant Treatment of Psychiatric Disorders
Burgess, J. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379156.lg13 · Cited by 2
Unraveling Gender Differences in Obsessive-Compulsive Disorder: A Focus on Key Micronutrients
Algin, S., Sajib, M. W. H., Ahmed, S. N., Siddique, M. R., Reza, M. T., Tanzilla, N. J., Ahmed, T., Islam, M. K., Patel, P., & Haque, M. (2025) · Cureus · doi:10.7759/cureus.79667 · Cited by 28
“Folate-deficient individuals, especially those with “treatment-resistant” depression, are more likely to experience severe affective disorders and respond poorly to conventional treatments [33,36].”
Folate for Treatment-Resistant Depression
Yager, J. (2013) · Journal watch · doi:10.1056/jp201301070000002
Behandlung depressiver Störungen
Schmauß, M., & Messer, T. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1849-8_1
Ernährungsaspekte von Sporttraining bei psychischen Störungen
Prvulovic, D., & Zopf, Y. (2015) · Springer eBooks · doi:10.1007/978-3-662-46537-0_11
Vitamins, amino acids, and drugs and formulations used in nutrition
Onakpoya, I., & Aronson, J. K. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-62635-6.00034-6
Chapter 14. Pharmacological and Somatic Treatments for Major Depressive Disorder
Niciu, M. J., Sinclair, C. M., Zarate, C. A., & Shelton, R. C. (2014) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585625048.gg14
Self-citationIndividualized Treatment of Depression
(2013) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814343664_0010
Vitamin Deficiencies and Depression: Evidence-Based Research
Greenblatt, J. M., & Patel, P. (2015) · CRC Press eBooks · doi:10.1201/b19089-9
Folate Screening Pattern at the Psychiatric Inpatient Unit at HMC, Qatar-Quality Improvement Project
Zaraa, A. (2016) · Journal of Psychology & Clinical Psychiatry · doi:10.15406/jpcpy.2016.05.00301
“Moreover, adjuvant folate supplementation in addition to standard therapy has been shown a couple of studies including, 2 randomized, double-blind, parallel-sequential trials, to improve clinical response rates in folate deficient patients with SSRI resistant depression [10-12].”
BackgroundPerez, L. F. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
Integrative Geriatric Psychiatry
Glick, R. M., Gebara, M. A., & Lenze, E. J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190466268.003.0019
Pharmacogenomics in the Treatment of Child and Adolescent Psychiatric Disorders
Malik, S., Walker, S. A., Malik, S., & Namerow, L. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-815310-9.00010-1
Addressing High Placebo Response in Neuroscience Clinical Trials
Doros, G. D., Lim, P., & Liu, Y. (2018) · ICSA book series in statistics · doi:10.1007/978-981-10-7829-3_7
Ácido Fólico no Tratamento da Depressão: Uma Revisão Baseada na Evidência
Vicente, A. F., Chin, Â. L., & Vicente, F. P. (2018) · Gazeta Médica · doi:10.29315/gm.v5i4.215
The neurobiology of treatment-resistant depression
Shelton, R. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00004-9
Self-citationGómez-Juanes, R. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 4
Nutrition in Neurocognition and Mental Health
Katrinak, M., Irani, F., Armstrong, C. L., & Kerr, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_28
L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study.
Hardin, A., & Baldwin-Sayre, C. (2020) · PubMed
Ezeme, M. S., Okafor, U. H., & Samuel, E. (2021) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol06-i03/1054
“In other words, anaemia may be considered a risk factor for depression in CKD probably because alongside reduced blood levels there might also be deficient B Vitamins [19,20] and minerals [21] which are also predisposing factors for depression.”
BackgroundPsikiyatrik Bozukluklardaki Anksiyetenin Kanıta Dayalı Bitkisel ve Nutrisyonel Tedavisi
Tamam, L. (2021) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4
MTHFR GENE MUTATION AND ITS REPERCUSSION IN THE GENESIS AND TREATMENT OF DEPRESSION: CASE REPORT
Laux, A. L., Klochinski, A., Bobato, B. F., Dib, E. C. S., Sprung, H. A., Mallmann, J., & Rota, V. L. G. (2021) · International Journal of Scientific Research and Management (IJSRM) · doi:10.18535/ijsrm/v9i07.mp03
Bibliography: Psychopharmacology: Evidence and Treatments
(2014) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.12.2.184
Wahba, M., Sousa, S., Watson, S., Strawbridge, R., Young, A. H., & Lingford-Hughes, A. R. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.171
“This analysis included only a two-phase trial by Papakostas et al,12 which showed a statistically significant improvement in SSRI antidepressant effects with L-methylfolate at a dose of 15 mg and an underpowered trial by Reynolds et al13 that compared amitriptyline with L-methylfolate as…”
MethodVitamins, Amino Acids and Drugs and Formulations Used in Nutrition
Onakpoya, I. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-63407-8.00034-4
Augmentation Strategies for Treatment-Resistant Disorders
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372997.as09
Becker, M. A., Axelrod, D. A., Chism, K., & Bahnsen, R. (2018) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371990.jl23
Ernährungsaspekte bei psychischen Störungen
Prvulovic, D., & Zopf, Y. (2023) · Springer eBooks · doi:10.1007/978-3-662-67880-0_12
Natural Substances in the Adjuvant Therapy of Depression
Lucius, K. (2024) · Integrative and Complementary Therapies · doi:10.1089/ict.2024.27201.kl
Pharmacological Approaches to Depression and Treatment-Resistant Depression
Fava, M., Baek, J. H., Nierenberg, A. A., Mischoulon, D., Cusin, C., Cassano, P., & Papakostas, G. I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00051-5
Self-citationPharmacological Approaches to Depression and Treatment-Resistant Depression
Fava, M., Baek, J. H., Nierenberg, A. A., Mischoulon, D., Cusin, C., Cassano, P., & Papakostas, G. I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11972-9.00003-x
Self-citation(2018) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378630.bm01
Chapter 8. Supplements: Their Role in Helping and Not Helping
(2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379569.lg08
Sales, A. J., Maciel, I. D. S., & Guimarães, F. S. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100032
Amel, A. K., & Haghshenas, M. (2025) · Journal of Comprehensive Pediatrics · doi:10.5812/jcp-162489
Pharmacoepigenetics of mood disorders
Bellia, F., Ballerini, P., & D’Addario, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00019-0
Adjunctive strategies for treatment-resistant depression
Thase, M. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00011-6 · Cited by 1
Dietary intake, Cognition, and Psychological Health
Tuck, N.-J. (2023) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00046010
Radoš, I., Vuksan-Ćusa, Z., Milić, J., Šagud, M., Vrančić, A. L., Jakšić, N., Vuksan‐Ćusa, B., & Pivac, N. (2026) · Biomolecules · doi:10.3390/biom16010070
“The effectiveness of both folic acid and L-methylfolate, as an adjunctive antidepressant treat-ment, was found [13,14].”
Styczyńska, M., Wojewódzki, M., Cyrzan, A., Zalewski, J. Z., Zysk, A., Ząbek, M., Iwanowska, M., Flis, B., Goss, A., & Fronczak, B. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.88.68648
Moraes, J. B., Alfieri, D. F., Moriya, R. M., Reiche, E. M. V., Machado, R. C. B. R., & Nunes, S. O. V. (2026) · Epigenetics Reports · doi:10.1080/28361512.2026.2646172
Kerek, R. (2013) · theses.fr (ABES) · doi:10.70675/196aa26az8485z4ed2zb330ze572feb96fec · Cited by 1
Chaikali, S., & Jacobsen, J. P. R. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002180
Fanet, H. (2018) · theses.fr (ABES) · doi:10.70675/b46d2065zecc9z4e97zae20zf9e2e4fe0c69 · Cited by 1
Pajović, S. B., & Filipović, D. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0152
“Clinically, these mechanisms align with evidence that folate status can in fl uence Flx e ffi cacy, with supplementation improving SSRI response (Papakostas et al. 2012).”
Diet, Food, Supplements, and Depression
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_20
The relationship between vitamin B9 (folate) supplementation and suicidality: a scoping review
Noel, C., Lombardi, N., Price, M., Herbert, E., & Lavigne, J. E. (2026) · Mental Health Clinician · doi:10.9740/mhc.2026.06.150
“The RCT analyzed longitudinal outcomes using area-under-the-curve summaries across baseline and follow-up at weeks 4, 12, and 25.”
Suchołbiak, A., Mikołajczyk, O., Podolak, M., Walkowski, R. J., Grygutis, I., Jarzęcka, U., Fimiarz, K. J., Pawełkiewicz, S., & Łysak, K. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5541
From Nutrient to Nucleus: How Folic Acid Influences Epigenetic Programming and Gene Expression
Hegde, D., & Verma, P. (2026) · Asian Journal of Pharmaceutical Research · doi:10.52711/2231-5691.2026.00045
Biological Non-pharmacological Treatments for Depressive Disorder
Song, M., & Seo, J. S. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_16
A importância do metilfolato na prevenção dos defeitos abertos do tubo neural
Hsu, L. D. P. R. (2020) · Femina · doi:10.61622/0100-7254483202001
Magray, M. N. Z., Taufiq, L., Bari, S., & Naz, N. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2026.2718400
Beer, C., Rae, F., Watt, M., Trzaskowski, M., Yates, C. G., Semmler, A., & Voisey, J. (2026) · Nutrients · doi:10.3390/nu18172791
“Given these mechanistic intersections, nutritional deficiencies or genetic constraints affecting one-carbon metabolism may play a contrib-utory role in mood disorders, particularly in treatment-resistant or partially responsive presentations [32].”
InfluentialRoadmap for Mental Health Treatment Utilizing Pharmacogenomic Testing: Case Report
Swanson, A. P., Mewborn, E., & Bae, G. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72904
Mechlińska, A., Sudoł, N., Pazda-Juda, D., & Cubała, W. J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1961751
Ellul, G., Bitar, D. C., & Grech, G. (2026) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-032-32838-0_6
Nutrition as a Keystone of Balanced Physiology—Harnessing Human and Microbial Metabolic Synergy
Kumar, S., & Spiteri, C. (2026) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-032-32838-0_10
ANAS ALI ALHUR, E. A., & KINDAH ALTUWAIRQI, L. A. (2025) · TPM Testing, psychometrics, methodology in applied psychology
Mikronährstoffe, Supplemente und Nutraceuticals für die Psyche
Esfahani-Bayerl, N., & Garcia, S. L. (2026) · Springer eBooks · doi:10.1007/978-3-662-72335-7_18
Chapter 10. Diet Interventions
(2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550930.lg10
Ewald, M., Young, E. E., & Veatch, O. J. (2026) · Current Sleep Medicine Reports · doi:10.1007/s40675-026-00403-w
“…displays the set of mental health conditions included in the analysis, while the vertical bars represent the number of insomnia drug target genes shared essential molecules, such as folate, as an adjunct treatment for psychiatric conditions, particularly in treatment-resistant depression [ 45 ].”
Roles of Folate-Dependent Epigenetic Modifications in Major Depressive Disorder
Anal, C. K., Tiwari, S., & Paramanik, V. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06301-0
“A number of clinical studies suggest that folate-based interventions may have a role in the treatment of MDD, although the clinical utility of biomarkers such as folate status, homo-cysteine concentrations, and MTHFR genotype for patient stratification remains uncertain [29, 101, 102].”
Influential
Metadata
- Authors
- Papakostas, G. I., Shelton, R. C., Zajecka, J. M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E. D., Sacco, G. R., Schoenfeld, D., Pencina, M., Meisner, A., Bottiglieri, T., Nelson, E., Mischoulon, D., Alpert, J. E., Barbee, J. G., Zisook, S., & Fava, M.
- Affiliations
- Boston University (US)
- From the Center for Treatment-Resistant Depression, Depression Clinical and Research Program, the Biostatistics Center, and the Clinical Trials Network and Institute, Massachusetts General Hospital, Boston; Harvard Medical School, Boston; the Harvard Clinical Research Institute, Boston; the Department of Biostatistics, Boston University, Boston; the Department of Psychiatry, Vanderbilt University School of Medicine, Nashville; Rush University Medical Center, Chicago; the Department of Psychiatry,...
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2012-12
- Volume
- 169
- Issue
- 12
- Pages
- 1267-1274
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2136722242
- Cited by
- 275
- References
- 36
- Citations by year
- 2026: 21 · 2025: 8 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 20 · 2020: 18 · 2019: 22 · 2018: 27 · 2017: 19 · 2016: 26 · 2015: 26 · 2014: 25 · 2013: 25 · 2012: 1
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- 5-methyltetrahydrofolate, major depressive disorder, selective serotonin reuptake inhibitors, adjunctive therapy, treatment-resistant depression, antidepressant augmentation, response rate, adverse events, folic acid supplementation
- MeSH terms
- Major Depressive Disorder, Depressive Disorder, Major, Dose-Response Relationship, Drug, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Tetrahydrofolates, Treatment Outcome, Chemotherapy, Adjuvant, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.